Clinical Trial Update: IMMUNOREA - Immunological and Inflammatory Determinants Associated With the Prognosis of Intensive Care Patients

View source ↗

Summary

IMMUNOREA is a clinical trial studying immunological and inflammatory determinants of prognosis in intensive care patients; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Critical Illness, Intensive Care Patients | Status: RECRUITING